Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Advanced Solid Tumors With MAPK Pathway Mutations
View Full LandscapeTarget Indication
Advanced Solid Tumors With MAPK Pathway Mutations
Clinical Trial
NCT05886920Last updated: 12/16/2025
No patent data available. Pre-approval drugs may not have Orange Book listings.
Pulmonary Hypertension
Knee Osteoarthritis
Glabellar Frown Lines
AGA
Overweight or Obesity